Report Overview

The United States animal healthcare market is driven by growing adoption of companion animals in the country and rising awareness of animal diagnostics among pet owners. In addition, rising government and non-governmental organizations’ initiatives for the promotion and campaigns for animal health care coupled with penetration of e-commerce platforms also support the market growth in upcoming years.

United States Animal Healthcare Market - Industry Trends & Forecast Report 2028

The United States animal healthcare market anticipated grow at a lucrative CAGR of 7.6% over the forecast period of 2022-2028. The rapid expansion of the market is driven by growing adoption of companion animals in the country and rising awareness of animal diagnostics among pet owners. In addition, the government's support for the development of advanced technologies and the increasing number of research & development activities are also expected to fuel the market's development. The rising consumption of meat and milk products and the increasing number of food-borne zoonotic diseases are expected to drive the market's growth. Besides, the increasing disposable income of pet owners is also contributing in the market growth of animal healthcare the region.

The United States Animal Healthcare Market - Overview

Animal health was primarily in charge of ensuring that animals were in good health, free from sickness, and well-cared for. The prevention and control of animal sickness is essential for enhancing worldwide public health. Keeping animals healthy also contributes to the vitality and expansion of communities. Animal health is the cornerstone of thriving, expanding communities. The use of vaccines, drugs, and feed for animals is a crucial part of animal health care. This industry is focused on improving the well-being of farm and companion animals. Besides treating their conditions, the industry also provides various services and products such as vaccines, pet supplies, and medical devices.

The United States Animal Healthcare Market Forecast and Trends

Growth Drivers

Rising adoption of companion animals in the country

The market for animal healthcare is expanding in the region due to rising adoption of companion animals for security reasons, numerous human health advantages, and rising pet humanization. Companion animals are recognized to improve a person's general well-being by lowering blood pressure, promoting psychological stability, and reducing the frequency of anxiety attacks and cardiac arrhythmias. A significant factor driving the U.S. animal healthcare market is the growing number of pet owners looking for better healthcare options, higher-quality diets, and upscale grooming and training services for their companion animals. In addition, increased adoption rates of companion animals are due to the rise in domestic consumption and large exports of milk and meat. Hence aforementioned factor anticipated to drive pet adoption and contribute in market growth of animal healthcare.

Rising food-borne zoonotic diseases

Another important element fueling the expansion of the U.S. animal healthcare industry is the rising incidence of zoonotic diseases that are transmitted through food. Animal farm/livestock owners and companion owners are becoming increasingly concerned about animal health as a result of the rise in food-borne zoonotic diseases. Some communicable diseases in vertebrate animals, such as tuberculosis and avian flu, can be transmitted to people either directly or indirectly. Anisakiasis, a human zoonotic disease brought on by specific species of nematodes, can be contracted by consumers if they consume worms through undercooked fish. The prevalence of brucellosis, a disease that causes stillbirth, is rising in the United States. Therefore, there is a growing demand for animal healthcare products in the nation to address zoonotic infections that are spread through food.

Restraints

Restrictions imposed on the use of antibiotics by regulatory bodies

Restrictions on the use of antibiotics enforced by regulatory authorities is the key restraining factor impeding the expansion of the U.S. animal healthcare market. Animals get both therapeutic and non-therapeutic uses of antibiotics. It has been noted that giving animals an excessive amount of antibiotics has an impact on consumers' general health. The regulation limits the market for animal healthcare as antibiotics make up a significant portion of animal pharmaceutical medications, which is expected to hamper market growth of animal healthcare industry in upcoming years.

Impact of COVID-19 on the United States Animal Healthcare Market

Covid-19 had a favorable effect on market expansion in the United States. As the government modified its regulations to allow for more flexible veterinary inspections during the coronavirus pandemic, major firms such as Boehringer Ingelheim Animal Health concentrated on spreading their telemedicine solutions into the market. Numerous animal shelters, non-profit rescue groups, independent breeders, and pet shops noticed an upsurge in customer demand. At first, the possibility of animals contracting the disease from being so close to people existed. Various market participants introduce their products to help veterinarians, such as animal testing kits for animal healthcare.

The United States Animal Healthcare Market - By Animal Type

Farm/livestock and companion animals are the two categories under which the U.S. animal healthcare market based on type. In terms of revenue share in 2021, the livestock animal category dominated the market for animal health. The segment's significant market share is a result of government healthcare organizations’ widespread concern for food safety and sustainability. Besides, due to the growing adoption of companion animals by American homes, companion animals witness significant share in the industry. The American Pet Products Association's (APPA) 2017–18 National Pet Owners Survey found that 85 million families in the U.S. have a pet. Ruminants, classified as farm animals and include poultry, swine, and fish, accounted for the biggest market share. This is linked to the substantial export of beef and the rising domestic demand for goods derived from animals. As per the United States Department of Agriculture (USDA), the United States is the largest producer of beef in the world and the second-largest exporter of beef.

Animal Healthcare Market - By Product Type

Based on product type the United States animal healthcare market is majorly fragmented into vaccines, drugs, medicated feed additives, diagnostic and equipment and disposables. The demand for animal healthcare products is increasing due to an exponential rise in sickness frequency that has led firms to create improved vaccinations and treatments. The market's expansion is anticipated to be impacted by the approval of innovative treatments for animal illnesses. For instance, Felix Pharmaceuticals Pvt. Ltd. gained FDA approval in May 2020 for "Enrofloxacin Flavored Tablets" to treat bacterial diseases. In January 2020, Poulvac Procerta HVT-ND, a vectored recombinant vaccine for defense against Newcastle and Marek's disease viruses, was introduced by Zoetis, a leading provider of animal health products. Over the course of the projection period, the veterinary healthcare market in the United States will be driven by an increase in owners, product approvals, and government backing.

Competitive Landscape

Key players operating in the United States Animal Healthcare Market are Zoetis Inc., Merck & Co. Inc., Boehringer Ingelheim, Bayer, Virbac Group, Ceva Santé Animale, and Elanco Animal Health, Vetoquinol S.A, HIPRA, Huvepharma, Dechra pharmaceuticals plc, and other prominent players. Due to the presence of various manufacturing firms in the United States, the market for animal healthcare is quite fragmented. Market leaders maintain their dominance by investing in R&D, incorporating cutting-edge technology into their products, and providing improved products for customers. The major market players engage in mergers and acquisitions to expand their market position globally. For instance, Elanco's acquisition of Bayer has led to the distribution of their goods across other markets, including pharmaceuticals.

Recent Development

• In February 2020, Ethos Diagnostic Science is a veterinary reference lab that serves top speciality animal hospitals, and it was recently acquired by Zoetis Inc. By way of acquisitions, Zoetis is expanding its diagnostics presence and providing American vets with a comprehensive and improved service.
• In July 2022, The United States and the Philippines launched a new project aimed at strengthening local veterinary services for safe pork and pork products to support the Philippine swine industry in the long term.

Scope of the Report

By Animal Type

• Farm/Livestock Animals
• Poultry

1. Cattle
2. Swine
3. Fish

• Companion Animal

1. Dogs
2. Cats
3. Horses
4. Others

By Product Type

• Therapeutic
• Vaccine

1. Live Attenuated Vaccine
2. DNA Vaccines

• Drugs

1. Parasiticides
2. Anti-infective
3. Anti-inflammatory
4. Analgesics
5. Others

• Medicated Feed Additives
• Antibiotics
• Vitamins
• Amino acids
• Diagnostic
• Immunodiagnostic Tests
• Molecular Diagnostics
• Diagnostic Imaging
• Clinical Chemistry
• Other Diagnostics

• Equipment and Disposables

By Treatments

• Allergies
• Arthritis
• Dermatology Cases

By End User

• Veterinary Hospitals & Clinics
• Diagnostic Centres
• Others

By Distribution Channel

• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies
• Drug Stores
• Online